We are live on ! Find out more
ACM

Aster Capital Management Portfolio holdings

AUM $306M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$306M
AUM Growth
+$77.6M
Cap. Flow
+$124M
Cap. Flow %
40.69%
Top 10 Hldgs %
25.96%
Holding
1,464
New
410
Increased
195
Reduced
203
Closed
655

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$12.7M
2
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$9.41M
3
AAPL icon
Apple
AAPL
+$6.04M
4
WMT icon
Walmart Inc
WMT
+$4.99M
5
CMCSA icon
Comcast
CMCSA
+$4.23M

Sector Composition

Rank Sector Weight
1 Financials 17.55%
2 Technology 8.41%
3 Energy 8.03%
4 Industrials 7.35%
5 Consumer Staples 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTLO icon
726
Portillo's
PTLO
$329M
$3.13K ﹤0.01%
+263
New +$1.43K
ARWR icon
727
Arrowhead Research
ARWR
$12.1B
$3.11K ﹤0.01%
+244
New +$15.4K
VSH icon
728
Vishay Intertechnology
VSH
$5.43B
$3.07K ﹤0.01%
+193
New +$3.51K
KYMR icon
729
Kymera Therapeutics
KYMR
$8.25B
$3.06K ﹤0.01%
+112
New +$8.87K
RCKT icon
730
Rocket Pharmaceuticals
RCKT
$372M
$2.9K ﹤0.01%
+434
New +$1.73K
VMI icon
731
Valmont Industries
VMI
$9.43B
$2.85K ﹤0.01%
+10
New +$4.37K
VST icon
732
Vistra
VST
$52.6B
$2.82K ﹤0.01%
+24
New +$3.88K
INTA icon
733
Intapp
INTA
$2.57B
$2.8K ﹤0.01%
+48
New +$1.43K
UTHR icon
734
United Therapeutics
UTHR
$21.9B
$2.77K ﹤0.01%
9
-741
-99% -$369K
NTLA icon
735
Intellia Therapeutics
NTLA
$1.5B
$2.74K ﹤0.01%
+386
New +$4.92K
RPD icon
736
Rapid7
RPD
$680M
$2.68K ﹤0.01%
101
-1,486
-94% -$13.7K
SBH icon
737
Sally Beauty Holdings
SBH
$1.54B
$2.67K ﹤0.01%
296
-1,187
-80% -$18.1K
BBUC
738
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.42B
$2.63K ﹤0.01%
99
-63
-39% -$2.17K
IRON icon
739
Disc Medicine
IRON
$2.93B
$2.58K ﹤0.01%
+52
New +$3.61K
KOS icon
740
Kosmos Energy
KOS
$1.51B
$2.57K ﹤0.01%
+1,126
New +$2.12K
CNX icon
741
CNX Resources
CNX
$5.33B
$2.55K ﹤0.01%
+81
New +$3.16K
VG
742
Venture Global Inc
VG
$32.5B
$2.54K ﹤0.01%
247
-6,865
-97% -$73.6K
NOG icon
743
Northern Oil and Gas
NOG
$2.25B
$2.54K ﹤0.01%
+84
New +$2.17K
ARDX icon
744
Ardelyx
ARDX
$1.23B
$2.5K ﹤0.01%
+509
New +$3.37K
REPL icon
745
Replimune Group
REPL
$1B
$2.49K ﹤0.01%
+255
New +$1.95K
AVXL icon
746
Anavex Life Sciences
AVXL
$273M
$2.47K ﹤0.01%
+288
New +$1.25K
COGT icon
747
Cogent Biosciences
COGT
$6.64B
$2.45K ﹤0.01%
+409
New +$15.1K
VRTS icon
748
Virtus Investment Partners
VRTS
$1.13B
$2.41K ﹤0.01%
14
-293
-95% -$43.2K
JJSF icon
749
J&J Snack Foods
JJSF
$1.48B
$2.37K ﹤0.01%
18
-173
-91% -$15K
DYN icon
750
Dyne Therapeutics
DYN
$4.71B
$2.36K ﹤0.01%
226
-4,084
-95% -$70.4K

Similar funds

Aster Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Aster Capital Management held 1,464 positions worth $306M, up 34% from $228M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Aster Capital Management deployed $124M of net new capital in Q1 2026, opening 410 new positions and adding to 195 existing holdings. Its largest new stake was VanEck Oil Services ETF: 25,853 shares worth $6.78M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 12% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Broadcom, an estimated $12.7M trimmed.

  • Aster Capital Management's largest Q1 2026 buy was VanEck Oil Services ETF: 25,853 shares worth $6.78M.
  • Aster Capital Management added most to iShares Russell 2000 ETF in Q1 2026, an estimated $14M increase.
  • Aster Capital Management's biggest Q1 2026 reduction was Broadcom, cutting an estimated $12.7M.
  • Aster Capital Management fully exited Invesco S&P 500 Equal Weight ETF in Q1 2026, selling an estimated $9.41M.
  • Aster Capital Management's ten largest holdings make up 26% of its $306M portfolio in Q1 2026.
  • Aster Capital Management opened 410 new positions and closed 655 in Q1 2026.
  • Aster Capital Management's portfolio value rose 34% quarter-over-quarter to $306M.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.